Advances in the development of biomarkers for epilepsy
Over 50 million people worldwide have epilepsy. In nearly 30% of these cases, epilepsy
remains unsatisfactorily controlled despite the availability of over 20 antiepileptic drugs …
remains unsatisfactorily controlled despite the availability of over 20 antiepileptic drugs …
MicroRNAs in epilepsy: pathophysiology and clinical utility
Background Temporal lobe epilepsy is a common and frequently intractable seizure
disorder. Its pathogenesis is thought to involve large-scale alterations to the expression of …
disorder. Its pathogenesis is thought to involve large-scale alterations to the expression of …
Эпилепсия у детей и взрослых женщин и мужчин
ВА Карлов - 2019 - elibrary.ru
В руководстве представлены результаты 60-летней работы автора в области детской
и взрослой неврологии и эпилептологии. Впервые эпилептология представлена в …
и взрослой неврологии и эпилептологии. Впервые эпилептология представлена в …
Advances in the potential biomarkers of epilepsy
D Kobylarek, P Iwanowski, Z Lewandowska… - Frontiers in …, 2019 - frontiersin.org
Epilepsy is a group of chronic neurological disorders characterized by recurrent,
spontaneous, and unpredictable seizures. It is one of the most common neurological …
spontaneous, and unpredictable seizures. It is one of the most common neurological …
Dietary nutrition for neurological disease therapy: Current status and future directions
Adequate food intake and relative abundance of dietary nutrients have undisputed effects on
the brain function. There is now substantial evidence that dietary nutrition aids in the …
the brain function. There is now substantial evidence that dietary nutrition aids in the …
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus
There is a need for diagnostic biomarkers of epilepsy and status epilepticus to support
clinical examination, electroencephalography and neuroimaging. Extracellular microRNAs …
clinical examination, electroencephalography and neuroimaging. Extracellular microRNAs …
Down regulation of miR‐218, miR‐124, and miR‐144 relates to Parkinson's disease via activating NF‐κB signaling
RX Xing, LG Li, XW Liu, BX Tian… - The Kaohsiung Journal …, 2020 - Wiley Online Library
Parkinson's disease (PD) is a neurological degenerative disorder that is partially induced by
inflammation in the neural system. To explore the roles of disordered microRNAs in the …
inflammation in the neural system. To explore the roles of disordered microRNAs in the …
Identifying and targeting angiogenesis-related microRNAs in ovarian cancer
X Chen, LS Mangala, L Mooberry, E Bayraktar… - Oncogene, 2019 - nature.com
Current anti-angiogenic therapy for cancer is based mainly on inhibition of the vascular
endothelial growth factor pathway. However, due to the transient and only modest benefit …
endothelial growth factor pathway. However, due to the transient and only modest benefit …
MicroRNA‐induced silencing in epilepsy: opportunities and challenges for clinical application
MicroRNAs are master regulators of gene expression. Single microRNAs influence multiple
proteins within diverse molecular pathways and networks. Therefore, changes in levels or …
proteins within diverse molecular pathways and networks. Therefore, changes in levels or …
Silencing rno-miR-155-5p in rat temporal lobe epilepsy model reduces pathophysiological features and cell apoptosis by activating Sestrin-3
LG Huang, J Zou, QC Lu - Brain Research, 2018 - Elsevier
Temporal lobe epilepsy (TLE) is a chronic neurological disease characterized by recurrent
spontaneous seizures. MicroRNAs are dysregulated in various pathological conditions …
spontaneous seizures. MicroRNAs are dysregulated in various pathological conditions …